<DOC>
	<DOCNO>NCT01080716</DOCNO>
	<brief_summary>This study inpatient trial determine safety , immunogenicity efficacy WRSS1 candidate vaccine healthy Thai adult volunteer . This study design 2 part . - Part 1 blind , placebo-controlled inpatient trial total 20 volunteer ( 14 vaccinee 6 control ) determine safety immunogenicity . Volunteers vaccinate single oral dose 104 colony form unit ( cfu ) WRSS1 placebo give bicarbonate buffer . - Part 2 start approximately 60 day WRSS1 vaccination . This part inpatient phase II efficacy trial involve challenge S.sonnei 53G 10 vaccinee first part 10 naïve control .</brief_summary>
	<brief_title>Safety Efficacy Study WRSS1 , Shigella Sonnei Vaccine Candidate</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dysentery , Bacillary</mesh_term>
	<mesh_term>Dysentery</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . 2040 year old ; male female ; 2 . General good health determine screen evaluation great 30 day admission ; 3 . Normal bowel habit ( grade 12 stool one two stool per day least one stool per 2 day ; 4 . Sexually active female willing use birth control ( birth control pill , injection hormonal contraceptive , implant hormonal contraceptive , hormonal patch , IUD , sterilization effective contraceptive method , spermicidal product barrier method consider acceptable ) entire study ( start study day 30 ) 3 month completion study ( approximately total 6 month ) sexually inactive female ( sexual contact ) . Volunteers take birth control pill require use additional contraceptive method remain day cycle discharge VTC ( alteration gastrointestinal function oral vaccine challenge strain may lead unpredictable efficacy pill ) ; 5 . Will available willing continue participation second part study he/she randomly select ; 6 . Pass Assessment Understanding consent form . 1 . An acute chronic medical condition clinically significant abnormality physical exam , opinion investigator , would render vaccination challenge unsafe ; 2 . Current use iron zinc supplement within past 7 day ; current use antacid ( H2 blocker , omeprazole , OTC agent ) immunosuppressive drug ; 3 . Unwillingness follow study procedure 4 . Currently breastfeed , pregnant ( βHCG + ) planning become pregnant within 3 month completion study ; 5 . Allergy quinolone , sulfa , penicillin class antibiotic ; 6 . History follow condition within past 10 year : Arthritis ( two episode joint pain swell ) , Gastrointestinal disease ( diagnosed doctor irritable bowel disease , Crohn 's disease , ulcerative colitis ( biopsy confirm ) , celiac disease , stomach intestinal ulcer ) , Dyspepsia ( digestion heartburn require medication per week ) ; 7 . Lifetime previous history known/suspected Shigella diarrhea ( except volunteer receive vaccine Part 1 ) ; 8 . Lifetime history , active gallbladder disease ; 9 . HLA B27 Ag ( + ) ; AntiHIV ( + ) ; HBsAg ( + ) ; Anti HCV IgG Ab ( + ) ; abnormal screening test judge clinically significant judge PI subPI ( Values acceptable abnormal range table protocol ) mild anemia female ( Hct = 0.330.36 ) ; 10 . Lifetime history participation Shigella study ( except volunteer receive vaccine Part 1 ) ; 11 . Concurrent participation another experimental vaccine drug study within past 30 day ( except volunteer receive vaccine part1 ) ; 12 . Serological positive Shigella sonnei : antiShigella sonnei LPS IgG antibody titer serum &gt; 800 ( except volunteer receive vaccine Part 1 ) ; 13 . Receipt antimicrobial drug reason acute illness fever &gt; =38 oC within 7 day vaccination challenge ; 14 . Individuals household contact immunocompromised ; 15 . History major abdominal surgery laparotomy reason past 3 year , abdominal scar unclear origin ; 16 . Presence significant ova parasite Shigella bacteria stool ; 17 . Receipt follow ( include WRSS1 vaccine ) : license live , attenuated vaccine within 30 day challenge licensed subunit kill vaccine within 14 day challenge blood product , include immunoglobulin , 90 day challenge</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>